Literature DB >> 17153525

Issues surrounding a reduction in the use of internal autopsy in the coronial system.

Belinda Carpenter1, Michael Barnes, Charles Naylor, Glenda Adkins, Brendan White.   

Abstract

In 2003 it was estimated that 2,700 full internal coronial autopsies were performed in Queensland at a cost of approximately A$5.3 million. This large number of internal coronial autopsies (almost 95% of all matters referred to the coroner) is of concern not only due to the economic cost but also because of the public heath risks, availability of specialist staff and significant religious and cultural sensitivities surrounding internal autopsies. In 2005 the authors began research funded by the Australian Research Council (ARC) to determine if unnecessary internal autopsies are being performed in Queensland and to establish guidelines for when an internal autopsy is required. This article highlights areas of potential concern when the issue of autopsy is reviewed within the coronial system through an examination of international literature on the issue of autopsy diagnosis and error rates more generally, and through preliminary discussion of the data obtained. The article considers the role and purpose of the autopsy generally as well as within the coronial system specifically; compares diagnostic error rates in hospital autopsies with those in the coronial system; the current situation internationally with regard to internal autopsies; and finally the specific circumstances existing in Queensland.

Entities:  

Mesh:

Year:  2006        PMID: 17153525

Source DB:  PubMed          Journal:  J Law Med        ISSN: 1320-159X


  2 in total

1.  The autopsy imperative: medicine, law, and the coronial investigation.

Authors:  Belinda Carpenter; Gordon Tait
Journal:  J Med Humanit       Date:  2010-09

Review 2.  How can we reduce the number of coroner autopsies? Lessons from Scotland and the Dundee initiative.

Authors:  Derrick Pounder; Matthew Jones; Heiko Peschel
Journal:  J R Soc Med       Date:  2011-01       Impact factor: 5.344

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.